Abstract
AbstractProgressive inflammation of one hemisphere characterises Rasmussen’s encephalitis (RE), but contralesional epileptiform activity has been repeatedly reported. We aimed to quantify contralesional epileptiform activity in RE and uncover its functional and structural underpinnings. We retrospectively ascertained people with RE treated between 2000 and 2018 at a tertiary centre (Centre 1) and reviewed all available EEG datasets. The temporal occurrence of preoperative contralesional epileptiform activity (interictal/ictal) was evaluated using mixed-effects logistic regression. Cases with/without contralesional epileptiform activity were compared for cognition, inflammation (ipsilesional brain biopsies), and MRI (cortical and fixel-based morphometry). EEG findings were validated in a second cohort treated at another tertiary centre (Centre 2) between 1995 and 2020. We included 127 people with RE and 687 EEG samples. Preoperatively, contralesional epileptiform activity was seen in 30/68 (44%, Centre 1) and 8/59 (14%, Centre 2). In both cohorts, this activity was associated with younger onset age (OR = 0.9; 95% CI 0.83–0.97; P = 0.006). At centre 1, contralesional epileptiform activity was associated with contralesional MRI alterations, lower intelligence (OR = 5.19; 95% CI 1.28–21.08; P = 0.021), and impaired verbal memory (OR = 10.29; 95% CI 1.97–53.85; P = 0.006). After hemispherotomy, 11/17 (65%, Centre 1) and 28/37 (76%, Centre 2) were seizure-free. Contralesional epileptiform activity was persistent postoperatively in 6/12 (50%, Centre 1) and 2/34 (6%, Centre 2). Preoperative contralesional epileptiform activity reduced the chance of postoperative seizure freedom in both cohorts (OR = 0.69; 95% CI 0.50–0.95; P = 0.029). Our findings question the concept of strict unilaterality of RE and provide the evidence of contralesional epileptiform activity as a possible EEG predictor for persisting postoperative seizures.
Funder
BONFOR research commission of the Medical Faculty of the University of Bonn
Universitätsklinikum Bonn
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Varadkar S, Bien CG, Kruse CA et al (2014) Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol 13:195–205. https://doi.org/10.1016/S1474-4422(13)70260-6
2. Bien CG, Granata T, Antozzi C et al (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitisA European consensus statement. Brain 128:454–471. https://doi.org/10.1093/brain/awh415
3. Rasmussen T, Olszewski J, Lloyd-Smith D (1958) Focal seizures due to chronic localized encephalitis. Neurology 8:435–435. https://doi.org/10.1212/WNL.8.6.435
4. Bien CG, Schramm J (2009) Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 86:101–112. https://doi.org/10.1016/j.eplepsyres.2009.06.001
5. So N, Gloor P (1991) Electroencephalographic and electrocorticographic findings in chronic encephalitis of the Rasmussen type. Chronic encephalitis and epilepsy Rasmussen’s syndrome. Butterworth-Heinemann, Boston, pp 37–45